EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Emerging role of nanotechnology in treatment of non-alcoholic fatty liver disease (NAFLD)

Atie Moghtadaie, Hamidreza Mahboobi, Somayeh Fatemizadeh, Mohammad Amjad Kamal

EXCLI Journal · 04.09.2023 · 22 · 946-974

DOI: 10.17179/excli2023-6420 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift EXCLI Journal, online erschienen am 04.09.2023. Verfasst von Atie Moghtadaie und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Fellow in Gastroenterology and Hepatology, Digestive Disease Research Institute, Department of Gastroenterology and Hepatology, Shariati Hos…. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-alcoholic fatty liver disease (NAFLD) is a prevailing health challenge that requires urgent innovative interventions. This review explores the role of nanotechnology as a promising potential in the treatment of NAFLD. It delineates the limitations of the current management strategies for NAFLD and highlights the new nanotechnology-based treatments including nanoemulsions, liposomes, micelles, polymeric nanoparticles, nanogels, inorganic nanoparticles, and zinc oxide nanoparticles. Despite the optimism surrounding the nanotechnological approach, the review underscores the need to address the limitations such as technical challenges, potential toxicity, and ethical considerations that impede the practical application of nanotechnology in NAFLD management. It advocates for collaborative efforts from researchers, clinicians, ethicists, and policymakers to achieve safe, effective, and equitable nanotechnology-based treatments for NAFLD.

Schlagwörter

Stichwörter der Autor:innen

MAFLDNAFLDinorganic nanoparticlesnanoemulsionsnanotechnologynon-alcoholic fatty liver diseasepolymeric nanoparticles

Autor:innen und Institutionen

  • Clinical Fellow in Gastroenterology and Hepatology, Digestive Disease Research Institute, Department of Gastroenterology and Hepatology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Gastroenterology and Hepatology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, China.
  • King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
  • Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh.
  • Enzymoics, 7 Peterlee place, Hebersham, NSW 2770; Novel Global Community Educational Foundation, Australia.

Zitieren

APA

Moghtadaie, A., Mahboobi, H., Fatemizadeh, S., & Kamal, M. A. (2023). Emerging role of nanotechnology in treatment of non-alcoholic fatty liver disease (NAFLD). EXCLI Journal, 22, 946-974. https://doi.org/10.17179/excli2023-6420

Vancouver

Moghtadaie A, Mahboobi H, Fatemizadeh S, Kamal MA. Emerging role of nanotechnology in treatment of non-alcoholic fatty liver disease (NAFLD). EXCLI Journal. 2023;22:946-974. doi:10.17179/excli2023-6420

BibTeX
@article{Moghtadaie2023,
  author = {Moghtadaie, Atie and Mahboobi, Hamidreza and Fatemizadeh, Somayeh and Kamal, Mohammad Amjad},
  title = {Emerging role of nanotechnology in treatment of non-alcoholic fatty liver disease (NAFLD)},
  journal = {EXCLI Journal},
  year = {2023},
  volume = {22},
  pages = {946--974},
  doi = {10.17179/excli2023-6420}
}
Kostenlos starten →